Conduit Pharmaceuticals Inc. financial data

Symbol
CDT, CDTTW on Nasdaq
Location
4851 Tamiami Trail North, Suite 200, Naples, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.9 % -43.7%
Debt-to-equity -346 % +6.97%
Return On Equity 845 % +252%
Return On Assets -343 % -289%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.06M shares -96.8%
Common Stock, Shares, Outstanding 2.39M shares -96.8%
Entity Public Float 41.4M USD +78.3%
Common Stock, Value, Issued 19K USD +171%
Weighted Average Number of Shares Outstanding, Basic 1.1M shares +2141%
Weighted Average Number of Shares Outstanding, Diluted 1.1M shares +2141%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6M USD +7340%
General and Administrative Expense 11.9M USD +36.5%
Operating Income (Loss) -17.9M USD -99.8%
Nonoperating Income (Expense) -1.76M USD -161%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.14M USD -49.1%
Income Tax Expense (Benefit) 213K USD +616%
Net Income (Loss) Attributable to Parent -19.6M USD -224%
Earnings Per Share, Basic 86 USD/shares +95%
Earnings Per Share, Diluted 86 USD/shares +95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.33M USD +1421%
Other Assets, Current 51K USD
Assets, Current 6.39M USD +299%
Property, Plant and Equipment, Net 381K USD +662%
Operating Lease, Right-of-Use Asset 204K USD -36.1%
Intangible Assets, Net (Excluding Goodwill) 5K USD
Assets 7.99M USD +142%
Accounts Payable, Current 1.25M USD +17.8%
Employee-related Liabilities, Current 40K USD -88.2%
Accrued Liabilities, Current 24.5K USD -82.3%
Liabilities, Current 4.41M USD -48.7%
Operating Lease, Liability, Noncurrent 46K USD -67.4%
Liabilities 4.46M USD -49.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 269K USD -30.5%
Retained Earnings (Accumulated Deficit) -39.9M USD -97.1%
Stockholders' Equity Attributable to Parent 3.53M USD
Liabilities and Equity 7.99M USD +142%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.93M USD -66.7%
Net Cash Provided by (Used in) Financing Activities 5.93M USD
Net Cash Provided by (Used in) Investing Activities -404K USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 2.41M shares -96.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.58M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 170K USD +113%
Deferred Tax Assets, Valuation Allowance 4.46M USD +207%
Deferred Tax Assets, Gross 4.46M USD +207%
Operating Lease, Liability 226K USD
Payments to Acquire Property, Plant, and Equipment 404K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.8M USD -246%
Lessee, Operating Lease, Liability, to be Paid 253K USD
Operating Lease, Liability, Current 138K USD -4.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 113K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 140K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 27K USD
Deferred Tax Assets, Operating Loss Carryforwards 2.97M USD +265%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 43.2M USD +201%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 10K USD
Interest Expense 100K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%